antipsychotics

Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study
Reuters
Mon, 03/11/24 - 04:56 pm
Acadia Pharma
antipsychotics
clinical trials
schizophrenia
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
Tue, 01/31/23 - 12:31 pm
Teva Pharmaceutical
clinical trials
schizophrenia
Eli Lilly
antipsychotics
Olanzapine
TV-44749
Karuna seeks a novel schizophrenia mechanism
EP Vantage
Thu, 06/23/22 - 10:31 am
Karuna Therapeutics
antipsychotics
schizophrenia
KarXT
U.S. Supreme Court rejects J&J appeal over Risperdal drug
Reuters
Tue, 05/18/21 - 11:37 pm
JNJ
Risperdal
off-label
antipsychotics
Supreme Court
Acadia fails in attempt to expand use of antipsychotic to treat patients with depression
Stat
Mon, 07/20/20 - 11:54 pm
Acadia Pharma
clinical trials
major depression
Nuplazid
major depressive disorder
antipsychotics
Philadelphia generic drugmaker slashes workforce by 8.5% after competitor emerges
Beckers Hospital Review
Mon, 07/13/20 - 11:39 pm
Lannett
layoffs
Amneal
Fluphenazine
generics
antipsychotics
Could immuno-oncology treatments get a boost from a 64-year-old antipsychotic?
Fierce Biotech
Fri, 03/6/20 - 10:52 am
cancer
immuno-oncology
prochlorperazine
antipsychotics
drug repurposing
Upcoming events – Acadia hopes for new indications for Nuplazid
EP Vantage
Fri, 05/3/19 - 10:18 am
Acadia Pharmaceuticals
antipsychotics
Nuplazid
schizophrenia
dementia
Schizophrenia therapy developer Karuna seeking IPO
BioCentury
Fri, 04/26/19 - 11:37 am
IPOs
Karuna
antipsychotics
schizophrenia
Bristol-Myers Squibb settles with Mass., other states over Abilify marketing
Bizjournals.com
Thu, 12/8/16 - 11:22 pm
Bristol-Myers Squibb
Abilify
antipsychotics
Allergan's Vraylar launch a success, despite trial failure
BioPharma Dive
Tue, 08/9/16 - 10:40 am
Allergan
Vraylar
drug launches
clinical trials
antipsychotics
Geodon Richter
J&J's Janssen hit with $70 mln verdict in Risperdal trial
Yahoo/Reuters
Sat, 07/2/16 - 12:41 pm
JNJ
Janssen
Risperdal
antipsychotics
FDA flags safety risks for Lilly antipsychotic drug
BioPharma Dive
Tue, 05/10/16 - 03:06 pm
FDA
Eli Lilly
antipsychotics
Symbyax
Zyprexa
Olanzapine
U.S. justices reject Johnson & Johnson unit's anti-psychotic drug appeal
Yahoo/Reuters
Mon, 01/11/16 - 11:58 am
JNJ
antipsychotics
Risperdal
Janssen
J&J loses another lawsuit tying Risperdal to male breasts
Stat
Mon, 12/14/15 - 10:13 pm
JNJ
Risperdal
gynecomastia
antipsychotics
J&J slapped with $1.75M verdict in Risperdal breast growth case
Fierce Pharma
Wed, 11/11/15 - 10:01 am
JNJ
Risperdal
antipsychotics
gynecomastia
2nd time's the charm for Allergan, Richter antipsychotic drug
BioPharma Dive
Mon, 09/21/15 - 11:08 am
Allergan
Richter
antipsychotics
cariprazine
Janssen Pharmaceuticals Accused of Hiding Risperdal's Breast Effects In Boys
Forbes
Sun, 08/30/15 - 11:56 am
Janssen
JNJ
Risperdal
gynecomastia
antipsychotics
Study: Off-label use of antipsychotics growing in teens/young adults
BioPharma Dive
Mon, 07/13/15 - 11:38 am
off-label
antipsychotics
FDA approves Otsuka and Lundbeck's schizophrenia treatment
Yahoo/Reuters
Fri, 07/10/15 - 10:53 pm
FDA
Otsuka
Lundbeck
schizophrenia
Rexulti
antipsychotics

Pages